Vaginal Itching: When to See a Doctor and What's Actually Causing It

What Actually Causes Vaginal Itching?

Vaginal itching rarely has a single universal explanation. The cause shifts depending on your age, hormonal status, sexual activity, and skin health. Getting the cause right matters because the treatments are completely different. Treating presumed yeast when you actually have BV, for example, delays relief and may worsen the bacterial imbalance.

Yeast Infection (Vulvovaginal Candidiasis)

Vulvovaginal candidiasis (VVC) is caused by Candida albicans in roughly 90 percent of cases. The classic picture is thick, white, cottage-cheese-like discharge paired with intense itching and vulvar redness. Vaginal pH is normal (below 4.5), which helps distinguish it from BV.

Approximately 75 percent of women will have at least one episode of VVC in their lifetime, and 40-45 percent will have a second episode. Risk factors specific to women include high-dose estrogen contraceptives, pregnancy (elevated estrogen and glycogen drive Candida overgrowth), antibiotic use, uncontrolled diabetes, and immunosuppression.

Recurrent VVC (four or more episodes per year) affects roughly 5-8 percent of women of reproductive age and may signal an underlying condition such as undiagnosed diabetes, PCOS-related insulin resistance, or an immunodeficiency. Non-albicans Candida species (particularly Candida glabrata) are more resistant to standard azole therapy and require different treatment.

Bacterial Vaginosis (BV)

BV is the most common vaginal condition in women aged 15-44, affecting an estimated 21.2 million women in the United States annually. It results from a shift in vaginal flora, with Lactobacillus species declining and anaerobic bacteria such as Gardnerella vaginalis proliferating. Vaginal pH rises above 4.5.

BV classically produces a thin, gray-white discharge with a fishy odor, especially after sex. Itching is present but often milder than with a yeast infection. BV is not sexually transmitted in the classic sense, but it is associated with sexual activity and recurrence after treatment is frustratingly common, with 50-70 percent of women experiencing recurrence within 12 months.

Contact Dermatitis and Skin Irritants

The vulvar skin is thin, moist, and highly sensitive. Scented soaps, laundry detergents, dryer sheets, synthetic underwear, lubricants, latex condoms, and menstrual products are common triggers for contact dermatitis. The itching from irritant or allergic contact dermatitis may be indistinguishable from an infection without a careful history.

Switching to fragrance-free, dye-free products and wearing loose cotton underwear resolves many cases within one to two weeks.

Genitourinary Syndrome of Menopause (GSM)

In perimenopause and postmenopause, falling estrogen levels cause the vaginal epithelium to thin, lose elasticity, and become less acidic. This is called genitourinary syndrome of menopause (GSM), formerly known as vulvovaginal atrophy. The Menopause Society (NAMS) estimates that over 50 percent of postmenopausal women experience symptoms of GSM, including vaginal dryness, itching, burning, and dyspareunia.

GSM does not resolve on its own. It typically worsens over time without treatment, and it is one of the most under-reported and under-treated conditions in women's health. If you are in perimenopause or postmenopause and experiencing vaginal itching, GSM should be near the top of the differential.

Lichen Sclerosus

Lichen sclerosus (LS) is a chronic inflammatory skin condition affecting the vulva and perianal area. It causes intense itching, white parchment-like patches, and over time, architectural changes including labial fusion and clitoral phimosis. ACOG and current dermatologic guidance recognize LS as having a bimodal age distribution: it peaks in prepubertal girls and again in postmenopausal women, though it can occur at any age.

Untreated LS carries a small but real risk of progression to squamous cell carcinoma of the vulva, making accurate diagnosis and long-term treatment with high-potency topical corticosteroids (typically clobetasol propionate 0.05%) essential. Self-diagnosis is not possible from symptoms alone.

Sexually Transmitted Infections

Trichomoniasis, caused by the protozoan Trichomonas vaginalis, produces a frothy, yellow-green discharge with vulvar itching and inflammation. The CDC reports an estimated 2.6 million new trichomoniasis infections in the United States each year. Herpes simplex virus (HSV) can cause vulvar itching or burning, sometimes before visible lesions appear. Chlamydia and gonorrhea less commonly cause itching but can produce discharge and pelvic discomfort.

Any new sexual partner, unprotected sex, or symptoms that do not fit the classic yeast picture warrants STI testing.

Vulvodynia and Lichen Planus

Vulvodynia is chronic vulvar pain and discomfort, including burning and itching, without an identifiable infectious or dermatologic cause. An estimated 8 percent of women meet criteria for vulvodynia before age 40. Diagnosis requires ruling out all other causes. Lichen planus, another inflammatory skin condition, can cause erosive lesions and itching on the vulva and vaginal mucosa and may be associated with oral lichen planus.

PCOS and Metabolic Factors

Women with PCOS have higher rates of insulin resistance and, in some studies, higher rates of recurrent candidiasis. Elevated blood glucose, even in the pre-diabetic range, creates a favorable environment for Candida overgrowth. If you have PCOS and experience recurrent yeast infections, discussing metabolic screening with your provider is worthwhile.

How Vaginal Itching Is Diagnosed

A correct diagnosis depends on office testing, not symptoms alone. Studies show that self-diagnosis of yeast infection is accurate in only about 34 percent of women who have not been previously diagnosed by a clinician, meaning most women who treat themselves for yeast actually have a different condition.

What Your Clinician Will Do

Your clinician will typically:

• Take a detailed history covering symptom timing, discharge characteristics, recent antibiotic or hormonal medication use, new products, and sexual history
• Measure vaginal pH using a simple swab test (normal pH is 3.8-4.5; elevated pH suggests BV, trichomoniasis, or atrophy)
• Perform a wet mount microscopy to look for Candida hyphae, clue cells (BV), or trichomonads
• Order a nucleic acid amplification test (NAAT) if STIs are possible
• Examine vulvar skin under magnification to identify lichen sclerosus, lichen planus, or other dermatoses
• Consider a vaginal culture or PCR panel if initial testing is inconclusive or if non-albicans Candida is suspected

At-Home pH Tests

Several over-the-counter vaginal pH test kits are available. A pH result above 4.5 suggests BV, trichomoniasis, or atrophy rather than a yeast infection. A normal pH does not confirm yeast (you can have yeast with a normal pH), but it reduces the probability of BV. These tests are a useful starting point, not a replacement for clinical evaluation.

When Should You Worry? Red Flags That Mean See a Doctor Now

Mild, short-lived itching after a new soap or just before your period is usually not alarming. These specific situations require prompt evaluation.

See a Doctor Within 24-48 Hours If:

• You have a fever, pelvic pain, or lower abdominal cramping alongside itching (possible pelvic inflammatory disease)
• You notice open sores, blisters, or ulcers on the vulva (possible herpes or other STI)
• You are pregnant and have new or worsening symptoms (treatment choice matters for fetal safety)
• You have recently had unprotected sex with a new partner

See a Doctor Within One Week If:

• Itching has lasted more than seven days without improvement
• Over-the-counter antifungal treatment (three to seven day course) did not resolve symptoms
• You have thick, white patches of skin on the vulva
• Discharge is unusually colored, foul-smelling, or blood-tinged outside of your period
• You have had four or more yeast infections in the past 12 months

The Postmenopausal or Perimenopausal Flag

If you are in perimenopause or postmenopause and have not been screened for GSM or vulvar skin conditions, vaginal itching that has lasted more than two to three weeks deserves evaluation regardless of severity. GSM and lichen sclerosus are both easy to miss, easy to treat once identified, and associated with real long-term consequences if left unaddressed.

Treatment Options by Cause

Treatment is cause-specific. Using the wrong treatment delays relief and can mask a more serious diagnosis.

Yeast Infection Treatment

Uncomplicated VVC (mild to moderate, infrequent): Over-the-counter intravaginal azoles (clotrimazole, miconazole, terconazole) are effective. A single-dose oral fluconazole 150 mg is equally effective and preferred by many women for convenience. Clinical trial data from multiple randomized controlled trials summarized in a Cochrane review show cure rates of approximately 80-90 percent with either route.

Recurrent VVC: The standard approach per ACOG Practice Bulletin is an induction phase of oral fluconazole 150 mg every 72 hours for three doses, followed by weekly suppressive therapy for six months. The FDA-approved ibrexafungerp (Brexafemme) and oteseconazole (Vivjoa) offer alternatives for women who cannot tolerate or do not respond to fluconazole.

Non-albicans Candida: Boric acid vaginal suppositories 600 mg nightly for 14 days are a common second-line approach. These are not FDA-approved for this indication but are supported by observational data and are widely recommended in clinical practice.

BV Treatment

BV is treated with metronidazole (oral 500 mg twice daily for seven days, or 0.75% vaginal gel once daily for five days) or clindamycin 2% vaginal cream for seven days, per CDC treatment guidelines. Recurrence is common. Extended suppressive therapy with metronidazole vaginal gel twice weekly for 16 weeks after initial treatment reduces recurrence rates in women with frequent BV episodes.

GSM Treatment

First-line options for GSM include vaginal moisturizers (used regularly, not just with sex) and vaginal lubricants. For women with bothersome symptoms who want more effective relief, low-dose local vaginal estrogen (cream, ring, or tablet) is safe and effective and carries minimal systemic absorption. Ospemifene (a selective estrogen receptor modulator taken orally) and prasterone (vaginal DHEA) are non-estrogen prescription options. For women with systemic menopause symptoms who also want GSM relief, systemic hormone therapy addresses both.

Lichen Sclerosus Treatment

High-potency topical corticosteroids, typically clobetasol propionate 0.05%, are the standard first-line treatment and can induce remission and prevent structural progression. Treatment is usually ongoing, not a short course. Regular vulvar self-examination and annual clinician review are recommended because of the small but real malignancy risk.

Contact Dermatitis

Remove the offending product. Avoid all scented vulvar products. Short courses of low-potency topical hydrocortisone (1%) may help acute inflammation. Avoid scratching, which disrupts the skin barrier and increases infection risk.

Vaginal Itching Across Your Life Stages

Your hormonal environment shapes which causes are most likely at any given time.

Reproductive Years (Roughly Ages 15-45)

Yeast infections and BV dominate this window. Hormonal contraceptives, particularly combined oral contraceptives, can alter vaginal flora and increase susceptibility to Candida in some women. Perimenstrual itching (just before or during your period) is common because the pH environment shifts as blood raises vaginal pH. Premenstrual Candida flares are a recognized pattern and may respond to single-dose fluconazole timed to the luteal phase.

Trying to Conceive and Fertility Treatment

Vaginal infections, particularly BV, are associated with increased risk of early pregnancy loss and preterm birth. Treating BV before attempting conception or during IVF cycles is part of many fertility protocols. If you are actively trying to conceive, discuss any recurrent vaginal symptoms with your reproductive endocrinologist or OB-GYN before your next cycle.

Pregnancy and Lactation

Pregnancy-specific guidance deserves its own structured framework because the stakes are higher and the treatment options narrow considerably.

Yeast infections in pregnancy: VVC is more common in pregnancy because rising estrogen and glycogen levels support Candida growth. Approximately 30 percent of pregnant women are colonized with Candida, and symptomatic infection is more frequent. Intravaginal azoles (clotrimazole 7-day course, miconazole) are considered safe in pregnancy and are the preferred treatment. Oral fluconazole is not recommended in pregnancy: a large Danish cohort study published in JAMA found a statistically significant association between first-trimester fluconazole exposure and spontaneous abortion, and a 2020 FDA Drug Safety Communication updated the label to state that oral fluconazole should be avoided in pregnancy unless the benefit clearly outweighs the risk.

BV in pregnancy: Untreated BV in pregnancy is associated with preterm birth and other adverse outcomes. Oral metronidazole 500 mg twice daily for seven days is the preferred treatment per ACOG. Metronidazole has been used throughout pregnancy without demonstrated fetal harm, though some clinicians avoid it in the first trimester when organogenesis is occurring. Discuss timing with your provider.

Trichomoniasis in pregnancy: Treated with metronidazole. Untreated trichomoniasis is associated with preterm labor and low birth weight.

Lactation: Topical intravaginal antifungals are not systemically absorbed in meaningful amounts and are considered safe during breastfeeding. Oral fluconazole is detectable in breast milk but has been used to treat nipple/breast candidiasis in breastfeeding women. If your provider recommends oral fluconazole while you are breastfeeding, the transfer is low and generally considered acceptable. Metronidazole passes into breast milk; most guidelines state it is compatible with breastfeeding for short courses, though some clinicians suggest pumping and discarding milk for 12-24 hours after a single high dose.

Contraception note: None of the treatments for vaginal infections require contraception themselves, but oil-based antifungal creams (including some intravaginal preparations) can degrade latex condoms and diaphragms. Use a non-latex barrier method or avoid sex during topical treatment if contraception is a priority.

Perimenopause

The hormonal fluctuations of perimenopause can cause both GSM symptoms and changes in vaginal flora, making itching more likely even before periods stop entirely. Do not assume that itching in your 40s is just a yeast infection. A clinical evaluation that includes vaginal pH testing will help distinguish atrophy-related itching from infection.

Postmenopause

GSM is the leading cause of vaginal itching in postmenopausal women. Lichen sclerosus is also more prevalent in this group. Infections can still occur, particularly in women who are sexually active or immunocompromised, but the differential is meaningfully different from the reproductive years. A clinician who dismisses postmenopausal vaginal itching without examining the vulvar skin and testing the vaginal pH is missing important diagnostic steps.

What You Can Do Before Your Appointment

While you wait for your appointment (or if you are deciding whether to go), these steps are reasonable:

• Stop using any new product applied to the vulvar area (soap, lotion, wipes)
• Switch to fragrance-free detergent for underwear
• Wear loose, breathable cotton underwear
• Avoid tight-fitting synthetic clothing
• Do not douche; douching disrupts vaginal flora and can worsen BV and yeast
• If you have had a clinician-confirmed yeast infection before and your symptoms are identical, a seven-day OTC azole course is reasonable, but see a doctor if symptoms do not resolve
• Track symptoms: timing relative to your menstrual cycle, any new products, discharge characteristics, and sexual history will all help your clinician reach a faster diagnosis

Avoid applying over-the-counter hydrocortisone to the vulva without guidance. In the setting of an active infection, steroids can blunt your immune response and worsen symptoms.

Evidence Gaps: What We Do Not Know Yet

Women have historically been under-represented in vaginal microbiome research, and most foundational data comes from studies of predominantly white, cisgender, reproductive-age women. The evidence base for GSM treatment in women with hormone-sensitive cancers (such as breast cancer survivors who cannot use estrogen) is growing but still limited. The optimal long-term management of recurrent BV remains an active area of research, with the vaginal microbiome and the role of the sexual partner still incompletely understood. A 2022 Lancet Infectious Diseases paper highlighted the gap in understanding how race, ethnicity, and socioeconomic factors influence vaginal dysbiosis diagnosis and treatment access. When your clinician recommends a treatment that feels unfamiliar, asking what the evidence base is for your specific situation (your age, hormonal status, and infection history) is entirely appropriate.

Who This Is Right for and Who Needs More Specialized Care

Treat yourself at home if:

• You have had a previous clinician-confirmed yeast infection and your symptoms are identical
• Symptoms are mild and limited to itching without skin changes
• You can identify a clear irritant (new soap, laundry detergent) and symptoms started within 48 hours of exposure

See a primary care provider or OB-GYN if:

• Symptoms have lasted more than seven days or OTC treatment failed
• You have new or unusual discharge
• You are pregnant
• You have four or more yeast infections per year
• You are perimenopausal or postmenopausal and have not been evaluated for GSM

See a vulvodynia specialist, dermatologist, or urogynecologist if:

• You have visible skin changes on the vulva (white patches, erosions, scarring)
• You have chronic itching lasting more than three months without a clear diagnosis
• Pain with sex is a prominent symptom alongside itching
• You have been diagnosed with lichen sclerosus and are not seeing improvement with standard corticosteroid therapy

As Dr. Elena Vasquez, WomanRx's medical reviewer and board-certified OB-GYN, notes: "The single most common mistake I see is women treating presumed yeast for two weeks before coming in, when the actual problem is BV, atrophy, or a skin condition. A vaginal pH test takes about 30 seconds and changes the entire management plan. Every woman deserves that 30 seconds."

If you are postmenopausal, ask your provider specifically whether you have been evaluated for GSM and lichen sclerosus, not just infection. These conditions are treatable, they are common, and they should not be something you simply live with.